These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 31088499)

  • 1. USMCA (NAFTA 2.0): tightening the constraints on the right to regulate for public health.
    Labonté R; Crosbie E; Gleeson D; McNamara C
    Global Health; 2019 May; 15(1):35. PubMed ID: 31088499
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analyzing the impact of trade and investment agreements on pharmaceutical policy: provisions, pathways and potential impacts.
    Gleeson D; Lexchin J; Labonté R; Townsend B; Gagnon MA; Kohler J; Forman L; Shadlen KC
    Global Health; 2019 Nov; 15(Suppl 1):78. PubMed ID: 31775767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. USMCA 2.0: a few improvements but far from a 'healthy' trade treaty.
    Labonté R; Gleeson D; McNamara CL
    Global Health; 2020 May; 16(1):43. PubMed ID: 32375823
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intellectual property and access to medicines: mapping public attitudes toward pharmaceuticals during the United States-Mexico-Canada Agreement (USMCA) negotiation process.
    Wong ASY; Cole CB; Kohler JC
    Global Health; 2021 Aug; 17(1):92. PubMed ID: 34416883
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TPPA and tobacco control: threats to APEC countries.
    Sy DK; Stumberg RK
    Tob Control; 2014 Nov; 23(6):466-70. PubMed ID: 25170023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trade, investment and public health: compiling the evidence, assembling the arguments.
    Labonté R
    Global Health; 2019 Jan; 15(1):1. PubMed ID: 30606214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Trans Pacific Partnership Agreement and Pharmaceutical Regulation in Canada and Australia.
    Lexchin J; Gleeson D
    Int J Health Serv; 2016 Oct; 46(4):597-613. PubMed ID: 27516183
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Regional Comprehensive Economic Partnership, Intellectual Property Protection, and Access to Medicines.
    Townsend B; Gleeson D; Lopert R
    Asia Pac J Public Health; 2016 Nov; 28(8):682-693. PubMed ID: 27920239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Potential Impact of the Transatlantic Trade and Investment Partnership (TTIP) on public health.
    De Vogli R; Renzetti N
    Epidemiol Prev; 2016; 40(2):95-102. PubMed ID: 27290886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new generation of trade policy: potential risks to diet-related health from the trans pacific partnership agreement.
    Friel S; Gleeson D; Thow AM; Labonte R; Stuckler D; Kay A; Snowdon W
    Global Health; 2013 Oct; 9():46. PubMed ID: 24131595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. International trade and investment law: a new framework for public health and the common good.
    Delany L; Signal L; Thomson G
    BMC Public Health; 2018 May; 18(1):602. PubMed ID: 29739460
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Critical Discourse Analysis of Intellectual Property Rights Within NAFTA 1.0: Implications for NAFTA 2.0 and for Democratic (Health) Governance in Canada.
    Mohamed FA; Chaufan C
    Int J Health Serv; 2020 Jul; 50(3):278-291. PubMed ID: 32019396
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Trans-Pacific Partnership: Is It Everything We Feared for Health?
    Labonté R; Schram A; Ruckert A
    Int J Health Policy Manag; 2016 Aug; 5(8):487-496. PubMed ID: 27694662
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The North American Free Trade Agreement and public health at the US-Mexico border.
    Waterman S; Stolp C
    Am J Public Health; 2004 Jul; 94(7):1077; author reply 1077-8. PubMed ID: 15226120
    [No Abstract]   [Full Text] [Related]  

  • 15. Revisiting the public health implications of the United States-Mexico- Canada agreement.
    Adekola TA
    Global Health; 2020 Jun; 16(1):50. PubMed ID: 32503571
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmaceutical patents and some international trade issues: Canada, the United States, and NAFTA.
    Tancer RS
    Clin Ther; 1993; 15(6):1177-84; discussion 1120. PubMed ID: 8111813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trade Agreements and Direct-to-Consumer Advertising of Pharmaceuticals.
    Gleeson D; Menkes DB
    Int J Health Policy Manag; 2018 Feb; 7(2):98-100. PubMed ID: 29524933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estimating the unintended impact of the North American free trade agreement on U.S. public health.
    Adu DT; Li W; Sawadgo WPM
    Soc Sci Med; 2023 Sep; 333():116140. PubMed ID: 37573675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trade agreements and the risks for the nursing workforce, nursing practice and public health: A scoping review.
    Kidgell D; Hills D; Griffiths D; Endacott R
    Int J Nurs Stud; 2020 Sep; 109():103676. PubMed ID: 32603925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protecting the autonomy of states to enact tobacco control measures under trade and investment agreements.
    Mitchell A; Sheargold E
    Tob Control; 2015 Jun; 24(e2):e147-53. PubMed ID: 25361743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.